伊朗的内脏利什曼病:流行病学与临床特征综述
Visceral leishmaniasis in Iran: Review of the Epidemiological and Clinical Features.
作者信息
Mohebali Mehdi
机构信息
Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences P. O. Box 14155-6446,Tehran, Iran ; Center for Research of Endemic Parasites of Iran (CREPI), Tehran University of Medical Sciences, Tehran, Iran.
出版信息
Iran J Parasitol. 2013 Jul;8(3):348-58.
Visceral leishmaniasis (VL) is a life-threatening vector-borne parasitic disease is distributed in some parts of the new world and old world. The disease is endemic in different parts of Iran. This review article has been focused on major topics of epidemiological aspects and clinical features of VL in Iran for the period of 2002 through 2012. For the detection of VL in humans as well as animal reservoir hosts, anti-Leishmania antibodies were detected using direct agglutination test (DAT) as a validated serological test. Parasitological examinations were performed on suspected VL patients as well as canines and rodents. Different molecular methods were used for identification of species and genotype/ or strain of Leishmania spp. isolated from infected humans, animal reservoir hosts and vectors. Altogether, 1698 out of 36081 (4.7%) human serum samples collected from 5 distinct geographical zones showed anti-Leishmania antibodies at titers ≥ 1:3200 using DAT. The majority of VL cases in the endemic areas were found among children up to 12 years old. Almost 75% of DAT-positive cases (≥1:3200) in endemic areas showed clinical signs and symptoms. Predominant signs and symptoms in 217 hospitalized patients with DAT positive (≥1:3200) results included paleness (99.5%), fever (96.9%), splenomegaly (91.5%), hepatomegaly (53.6%) and lymphadenopathy (21.1%). Integrated VL surveillance system in primary care using DAT, could decrease mortality and morbidity of the disease in the VL endemic areas of the northwestern Iran. Out of 7204 serum samples collected from domestic dogs in various geographical locations of Iran, 879 (12.2%) were DAT sero-positive at titers ≥ 1:320. L. infantum as the principal causative agent of the disease was isolated from infected humans, domestic and wild canines and rodents. The principal animal reservoir hosts of the infection are domestic and wild canines. Ph. kandelakii, Ph. perfiliewi transcaucasicus, Ph. tobbi in northwestern Iran; Ph. major s.l. (=Ph. neglectus), Ph. keshishiani, and Ph. alexandri in southern parts of Iran were molecularly and/or parasitologically positive for L. infantum infections. The zoonotic form of VL (ZVL) caused by L. infantum occurs sporadically in all geographical zones of Iran but in northwestern and southern parts of the country the disease is endemic. DAT as an appropriate and potential tool has been used for sero-diagnosis and sero-epidemiological of VL among humans as well as domestic and wild canines.
内脏利什曼病(VL)是一种由媒介传播的、危及生命的寄生虫病,分布于新世界和旧世界的一些地区。该病在伊朗的不同地区呈地方性流行。这篇综述文章聚焦于2002年至2012年期间伊朗内脏利什曼病的主要流行病学方面和临床特征。为了检测人类以及动物储存宿主中的内脏利什曼病,使用直接凝集试验(DAT)作为一种经过验证的血清学检测方法来检测抗利什曼原虫抗体。对疑似内脏利什曼病患者以及犬类和啮齿动物进行寄生虫学检查。使用不同的分子方法来鉴定从受感染的人类、动物储存宿主和媒介中分离出的利什曼原虫物种和基因型/或菌株。总共,从5个不同地理区域采集的36081份人类血清样本中,有1698份(4.7%)使用DAT检测出抗利什曼原虫抗体效价≥1:3200。流行地区的大多数内脏利什曼病病例发生在12岁以下的儿童中。流行地区几乎75%的DAT阳性病例(≥1:3200)出现临床体征和症状。217例DAT阳性(≥1:3200)结果的住院患者的主要体征和症状包括面色苍白(99.5%)、发热(96.9%)、脾肿大(91.5%)、肝肿大(53.6%)和淋巴结病(21.1%)。在伊朗西北部的内脏利什曼病流行地区,在初级保健中使用DAT的综合监测系统可以降低该病的死亡率和发病率。从伊朗不同地理位置的家犬采集的7204份血清样本中,有879份(12.2%)DAT血清学阳性,效价≥1:320。婴儿利什曼原虫作为该病的主要病原体,从受感染的人类、家养和野生犬类以及啮齿动物中分离出来。该感染的主要动物储存宿主是家养和野生犬类。在伊朗西北部,坎氏白蛉、外高加索白蛉、托比白蛉;在伊朗南部,硕大白蛉指名亚种(=疏忽白蛉)、凯氏白蛉和亚历山大白蛉在分子和/或寄生虫学上对婴儿利什曼原虫感染呈阳性。由婴儿利什曼原虫引起的人畜共患型内脏利什曼病(ZVL)在伊朗的所有地理区域都有零星发生,但在该国的西北部和南部地区该病呈地方性流行。DAT作为一种合适且有潜力的工具,已被用于人类以及家养和野生犬类内脏利什曼病的血清诊断和血清流行病学研究。